Regenerative potential of platelet-rich plasma added to xenogenic bone grafts in peri-implant defects: A histomorphometric analysis in dogs

Journal of Periodontology

Volumn 76, Issue 10, 2005, Pages 1637-1644

  Sánchez, Andrés R ^a   Sheridan, Phillip J ^a   Eckert, Steven E ^a   Weaver, Amy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dental implants; Growth factors; Plasma

Indexed keywords

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DEMINERALIZATION; BONE GRAFT; BONE REGENERATION; CONTROLLED STUDY; DOG; FREEZING; MALE; MORPHOMETRICS; NONHUMAN; OSTEOTOMY; RANDOMIZATION; THROMBOCYTE RICH PLASMA; TOOTH EXTRACTION; TOOTH IMPLANTATION; XENOGRAFT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PLATELETS; BONE MATRIX; BONE REGENERATION; BONE TRANSPLANTATION; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DOGS; GELS; GROWTH SUBSTANCES; MALE; MODELS, ANIMAL; OSSEOINTEGRATION; RANDOM ALLOCATION;

EID: 27844509924     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.10.1637     Document Type: Article

References (46)

1. Lew D, Marino AA, Startzell JM, Keller JC. A comparative study of osseointegration of titanium implants in corticocancellous block and corticocancellous chip grafts in canine ilium. J Oral Maxillofac Surg 1994; 52:952-958.
2. Tadjoedin ES, de Lange GL, Lyaruu DM, Kuiper L, Burger EH. High concentrations of bioactive glass material (BioGran) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 2002;13:428-436.
3. Cho KS, Choi Sh, Han KH, Chai JK, Wikesjö UME, Kim CK. Alveolar bone formation at dental implant dehiscence defects following guided bone regeneration and xenogeneic freeze-dried demineralized bone matrix. Clin Oral Implants Res 1998;9:419-428.
4. Young C, Sandtedt P, Skoglund A. A comparative study of anorganic xenogenic bone and autogenous bone implants for bone regeneration in rabbits. Int J Oral Maxillofac Implants 1999;14:72-76.
5. Schwartz Z, Mellonig JT, Carnes DL, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1996; 67:918-926.
6. Rodriguez A, Anastassov GE, Lee H, Buchbinder D, Wettan H. Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. J Oral Maxillofac Surg 2003;61:157-163.
7. Maiorana C, Sommariva L, Brivio P, Sigurta D, Santoro F. Maxillary sinus augmentation with anorganic bovine bone (Bio-Oss) and autologous platelet-rich plasma: Preliminary clinical and histologic evaluations. Int J Periodontics Restorative Dent 2003;23:227-235.
8. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529-535.
9. Garg AK. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update 2000;11:1-5.
10. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: Case Series. J Periodontol 2000;71:1654-1661.
11. Lozada JL, Caplanis N, Proussaefs P, et al. Platelet-rich plasma application in sinus graft surgery: Part I-Background and processing techniques. J Oral Implantol 2001;27:38-42.
12. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93-103.
13. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent 2001; 13:487-493.
14. Salata LA, Franke-Stenport V, Rasmusson L. Recent outcomes and perspectives of the application of bone morphogenetic proteins in implant dentistry. Clin Implant Dent Relat Res 2002;4:27-32.
15. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
16. Marx RE, Carlson ER, Eichstaedt RN, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85: 638-646.
17. Rosenberg ES, Torosian J. Sinus grafting using platelet-rich plasma - Initial case presentation. Pract Periodontics Aesthet Dent 2000;12:843-850.
18. Shanaman R, Filstein MR, Danesh-Meyer MJ. Localized ridge augmentation using GBR and platelet-rich plasma: Case reports. Int J Periodontics Restorative Dent 2001;21:345-355.
19. Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: Three bilateral case reports. Int J Periodontics Restorative Dent 2002;22:45-53.
20. Kim SG, Chun CH, Kim YK, Park JC, Lim SC. Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants 2002;17:86-94.
21. Kim SG, Chun CH, Kim YK, Park JC, Lim SC. A comparative study of osseointegration of Avana implants in a demineralized freeze-dried bone alone or with platelet-rich plasma. J Oral Maxillofac Surg 2002; 60:1018-1025.
22. Aghaloo TI, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study. J Oral Maxillofac Surg 2002;60:1176-1181.
23. Zechner W, Tangl S, Tepper G, et al. Influence of platelet-rich plasma on osseous healing of dental implants: A histologic and histomorphometric study in minipigs. Int J Oral Maxillofac Implants 2003;18: 15-22.
24. Fürst G, Gruber R, Tangl S, et al. Sinus grafting with autogenous platelet-rich plasma and bovine hydroxyapatite. A histomorphometric study in minipigs. Clin Oral Implants Res 2003;14:500-508.
25. Jakse N, Tangl S, Gilli R, et al. Influence of PRP on autogenous sinus grafts. Clin Oral Implants Res 2003; 14:578-583.
26. Fürst G, Gruber R, Tangl S, Sanroman F, Watzek G. Enhanced bone-to-implant contact by platelet-released growth factors in mandibular cortical bone: A histomorphometric study in minipigs. Int J Oral Maxillofac Implants 2003;18:685-690.
27. Lynch SE, Buser D, Hernandez D, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-1 combination on bone regeneration around titanium dental implants. Results of a pilot study on beagle dogs. J Periodontol 1991;62:710-716.
28. Stefani CM, Machado MA, Sallum EA, Sallum AW, Toledo S, Nociti H Jr. Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: A histometric study. Implant Dent 2000;9: 126-131.
29. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899.
30. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70: 139-150.
31. Boyne PJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 2001; 83(Suppl. 1):146-150.
32. Wikesjö UM, Qahash M, Thomson RC, et al. RhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 2004;15:194-204.
33. Kokubo S, Mochizuki M, Fukushima S, et al. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human morphogenetic protein-2 and a biodegradable carrier. Biomaterials 2004;25:1795-1803.
34. Seeherman HJ, Bouxsein M, Kim H, et al. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a non-human primate model. J Bone Joint Surg Am 2004;86-A:1961-1972.
35. Terheyden H, Jepsen S, Möller B, Tucker MM, Rueger DC. Sinus floor augmentation with simultaneous placing of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. Clin Oral Implants Res 1999; 10:510-521.
36. Groenveld HHJ, Van den Bergh JPA, Ten Bruggenkate CM, Tuinzing DB, Burger EH. Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralized bone matrix or autogenous bone. Comparison with non-grafted sites in a series of case reports. Clin Oral Implants Res 1999;10:499-509.
37. Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapatite-coated and titanium implants. J Arthroplasty 2000;15:339-346.
38. Barrack RL, Cook SD, Patron LP, Salkeld SL, Szuszczewicz E, Withecloud TS 3rd. Induction of bone in-growth from acetabular defects to a porous surface with OP-1. Clin Orthop 2003;417:41-49.
39. Sumner DR, Turner TM, Burchio AF, Gombotz WE, Urban RM, Galante JO. Enhancement of bone in-growth by transforming growth factor-beta. J Bone Joint Surg Am 1995;77:1135-1147.
40. Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteotomies, and implant fixation. Acta Orthop Scand Suppl 1998;283:2-37.
41. Ruskin JD, Hardwick R, Buser D, Dahlin C, Schenk RK. Alveolar ridge repair in a canine model using rhTGF-beta 1 with barrier membranes. Clin Oral Implants Res 2000;11:107-115.
42. Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair. Int J Dev Biol 1993;37:573-579.
43. Solheim E. Growth factors in bone. Int Orthop 1998;22:410-416.
44. Heldin CH, Wasteson A, Westermark B. Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation. J Biol Chem 1982;257: 4216-4221.
45. Assoian RK. Biphasic effects of type beta transforming growth factor on epidermal growth factor receptors in NRK fibroblasts. Functional consequences for epidermal growth factor-stimulated mitosis. J Biol Chem 1985;260:9613-9617.
46. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.